830 related articles for article (PubMed ID: 10826451)
1. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.
Heffelfinger JD; Dowell SF; Jorgensen JH; Klugman KP; Mabry LR; Musher DM; Plouffe JF; Rakowsky A; Schuchat A; Whitney CG
Arch Intern Med; 2000 May; 160(10):1399-408. PubMed ID: 10826451
[TBL] [Abstract][Full Text] [Related]
2. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group.
Dowell SF; Butler JC; Giebink GS; Jacobs MR; Jernigan D; Musher DM; Rakowsky A; Schwartz B
Pediatr Infect Dis J; 1999 Jan; 18(1):1-9. PubMed ID: 9951971
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options for pneumococcal pneumonia in Turkey.
Oncu S; Erdem H; Pahsa A
Clin Ther; 2005 Jun; 27(6):674-83. PubMed ID: 16117975
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
Feldman C
J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of betalactam therapy for community-acquired pneumonia in the era of drug-resistant Streptococcus pneumoniae: a randomized study of amoxicillin-clavulanate and ceftriaxone.
Rosón B; Carratalà J; Tubau F; Dorca J; Liñares J; Pallares R; Manresa F; Gudiol F
Microb Drug Resist; 2001; 7(1):85-96. PubMed ID: 11310807
[TBL] [Abstract][Full Text] [Related]
6. Drug treatment of pneumococcal pneumonia in the elderly.
Neralla S; Meyer KC
Drugs Aging; 2004; 21(13):851-64. PubMed ID: 15493950
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2005 Jun; 52(2):129-33. PubMed ID: 15964501
[TBL] [Abstract][Full Text] [Related]
8. Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Jones RN; Sader HS; Stilwell MG; Fritsche TR
Diagn Microbiol Infect Dis; 2007 May; 58(1):1-7. PubMed ID: 17408904
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial susceptibility of Streptococcus pneumoniae isolates from vaccinated and non-vaccinated patients with a clinically confirmed diagnosis of community-acquired pneumonia in Belgium.
Lismond A; Carbonnelle S; Verhaegen J; Schatt P; De Bel A; Jordens P; Jacobs F; Dediste A; Verschuren F; Huang TD; Tulkens PM; Glupczynski Y; Van Bambeke F
Int J Antimicrob Agents; 2012 Mar; 39(3):208-16. PubMed ID: 22245497
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for drug-resistant Streptococcus pneumoniae and antibiotic prescribing practices in outpatient community-acquired pneumonia.
Jenkins TC; Sakai J; Knepper BC; Swartwood CJ; Haukoos JS; Long JA; Price CS; Burman WJ
Acad Emerg Med; 2012 Jun; 19(6):703-6. PubMed ID: 22632455
[TBL] [Abstract][Full Text] [Related]
11. Bacteriological evidence of antibiotic failure in pneumococcal lower respiratory tract infections.
Klugman KP
Eur Respir J Suppl; 2002 Jul; 36():3s-8s. PubMed ID: 12168746
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae: integrated results from four open-label, multicenter, phase III clinical trials.
Fogarty CM; Greenberg RN; Dunbar L; Player R; Marrie TJ; Kojak CM; Morgan N; Williams RR
Clin Ther; 2001 Mar; 23(3):425-39. PubMed ID: 11318077
[TBL] [Abstract][Full Text] [Related]
13. Penicillin resistance not a factor in outcome from invasive Streptococcus pneumoniae community-acquired pneumonia in adults when appropriate empiric therapy is started.
Mufson MA; Chan G; Stanek RJ
Am J Med Sci; 2007 Mar; 333(3):161-7. PubMed ID: 17496734
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
[TBL] [Abstract][Full Text] [Related]
15. [Guidelines for treatment of pneumonia in intensive care units].
Emmi V
Infez Med; 2005; Suppl():7-17. PubMed ID: 16801748
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
17. Failure of levofloxacin treatment in community-acquired pneumococcal pneumonia.
Endimiani A; Brigante G; Bettaccini AA; Luzzaro F; Grossi P; Toniolo AQ
BMC Infect Dis; 2005 Nov; 5():106. PubMed ID: 16307682
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of twice-daily pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in the treatment of adults with community-acquired pneumonia in a country with a high prevalence of penicillin-resistant Streptococcus pneumoniae.
Siquier B; Sánchez-Alvarez J; García-Mendez E; Sabriá M; Santos J; Pallarés R; Twynholm M; Dal-Ré R;
J Antimicrob Chemother; 2006 Mar; 57(3):536-45. PubMed ID: 16446376
[TBL] [Abstract][Full Text] [Related]
19. Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.
Jacobs MR
Am J Med; 1999 May; 106(5A):19S-25S; discussion 48S-52S. PubMed ID: 10348060
[TBL] [Abstract][Full Text] [Related]
20. Treatment of pneumococcal pneumonia.
Pallares R
Semin Respir Infect; 1999 Sep; 14(3):276-84. PubMed ID: 10501315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
